InMed Pharmaceuticals Makes Progress on Alzheimer’s Drug
InMed Pharmaceuticals (INM) has released an update. InMed Pharmaceuticals has made significant strides in its pharmaceutical programs, ...
Eisai Gets Positive Opinion From CHMP In European Union For Lecanemab In Early Alzheimer's Disease
Eisai Co., Ltd. (ESALF.PK) and Biogen Inc. (BIIB) announced a positive opinion has been received from the Committee for Medicinal ...
European committee takes a second look at Alzheimer's drug and now says it should be approved
A European regulatory committee now recommends approval of the Alzheimer's treatment lecanemab a few months after rejecting ...
BioPharma Dive5h
Eisai wins over European regulators on Alzheimer’s drug Leqembi
A key regulatory committee sided against the drug this summer. But an appeal from Eisai appears to have worked, teeing ...
News Medical1d
Scientists uncover cerebrospinal fluid markers for Alzheimer's detection and treatment
Researchers map the unique genetic regulation of proteins in human cerebrospinal fluid, identifying potential targets for ...
Laredo Morning Times2d
Popeyes of Laredo contributes profits to the Walk To End Alzheimer’s of Laredo
"Popeyes of Laredo is always looking to give back to the community and sees the need for Alzheimer’s awareness and support," ...
News Medical3d
TYK2 inhibition may offer new strategy to reduce tau toxicity in Alzheimer's
"Many studies have shown that the accumulation of tau in neurons and glial cells in the brain is a main characteristic of Alzheimer's disease and at least 24 more neurological diseases," said first ...